# Influence of substitution patterns on the antimicrobial properties of pyrrole sulfonamide scaffolds

**Authors:** Ioana C. Marinas, Natalia Simionescu, Nicolae D. Andreiu, Ashraf Al-Matarneh, Tudor Pinteala, Mariana C. Chifiriuc, Cristina M. Al-Matarneh

PMC · DOI: 10.3389/fchem.2026.1726389 · Frontiers in Chemistry · 2026-02-06

## TL;DR

This paper explores how different chemical substitutions on pyrrole sulfonamide compounds affect their ability to fight bacteria and fungi, including their impact on virulence factors and skin compatibility.

## Contribution

The study reveals how substitution patterns influence antimicrobial and anti-virulence activity, and biocompatibility of pyrrole sulfonamide derivatives.

## Key findings

- Meta-substituted sulfonamides showed stronger antibacterial activity by inhibiting microbial carbonic anhydrases.
- Para-substituted derivatives exhibited superior antifungal activity and antibiofilm potential.
- Compounds were non-haemolytic and well tolerated by skin cells at low concentrations.

## Abstract

Two series of sulfonamide derivatives featuring a pyrrol-2-one core were synthesized and evaluated for their antimicrobial and anti-virulence features using Escherichia coli, Pseudomonas aeruginosa, and Candida albicans strains, in planktonic and biofilm growth state. Fourteen substituents were introduced on the pyrrole ring, and the sulfonamide group was shifted from meta- (Series B) to para-position (Series A). Meta-substituted sulfonamides generally exhibited stronger antibacterial activity, likely via selective inhibition of microbial β-/γ-class carbonic anhydrases, while para-substituted derivatives demonstrated superior antifungal activity and antibiofilm potential. Also, series A compounds were particularly effective in inhibiting virulence factors, including haemolysin (S. aureus), lipase and acidification (C. albicans), and lecithinase (P. aeruginosa). Structure–activity relationships revealed that para-substitution aligns with human CA II, correlated with an enhanced antifungal efficacy, whereas meta-substitution favors microbial CA targeting, explaining antibacterial selectivity. Antimicrobial efficacy correlated weakly with lipophilicity and solubility, underscoring species-specific activity. Lipophilicity increased skin permeability but decreased solubility, negatively affecting biocompatibility. However, none of the tested compounds were haemolytic at 1 mg/mL, and all were well tolerated by dermal fibroblasts and keratinocytes at 10 µM. Collectively, these results highlight the dual functionality of these derivatives as selective anti-virulence and antimicrobial agents, while their skin-friendly properties make them promising candidates for the treatment of dermal infections.

Chemical structures of sulfonamide pyrrol-2-one derivatives with 14 substituents are shown on the left. The middle section highlights antimicrobial testing against E. coli, P. aeruginosa, and C. albicans, all marked with checks. The right section indicates dermal infection treatment potential and inhibition of virulence factors like haemolysin, lecithinase, and lipase, all marked as successful.

## Linked entities

- **Proteins:** lipase (lipase)
- **Chemicals:** sulfonamide (PubChem CID 5333)
- **Species:** Escherichia coli (taxon 562), Pseudomonas aeruginosa (taxon 287), Candida albicans (taxon 5476), Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Genes:** Lipase [NCBI Gene 17374477]
- **Diseases:** invasive candidiasis (MESH:D058365), inflammation (MESH:D007249), wounds (MESH:D014947), nosocomial infections (MESH:D003428), cytotoxic (MESH:D064420), infected chronic wounds (MESH:D014946), forming (MESH:C565541), tumoral (MESH:D009369), infection (MESH:D007239), Candidemia (MESH:D058387), haemolytic (MESH:D006463), irritation (MESH:D001523), mucosal candidiasis (MESH:D002177), hypoxic (MESH:D002534), haemorrhage (MESH:D006470), bacterial infections (MESH:D001424), Hemolysis (MESH:D006461), dermal (MESH:D016136), necrosis (MESH:D009336)
- **Chemicals:** pyrrocidine A (MESH:C508751), zinc (MESH:D015032), -SA (MESH:D000077145), aminoglycosides (MESH:D000617), quinazolinones (MESH:D052999), NaCl (MESH:D012965), pyrrolidine (MESH:C032519), thiolutin (MESH:C006361), methanol (MESH:D000432), crystal violet (MESH:D005840), 14B (-), benzimidazoles (MESH:D001562), pyruvic acid (MESH:D019289), carbohydrate (MESH:D002241), oxazolones (MESH:D010081), 11A (MESH:C027406), ketoconazole (MESH:D007654), amino acids (MESH:D000596), Sulfonamide (MESH:D013449), quinolines (MESH:D011804), nitrogen (MESH:D009584), holomycin (MESH:C015265), thiazole (MESH:D013844), lipid (MESH:D008055), iron (MESH:D007501), lipopolysaccharides (MESH:D008070), Pyrrole (MESH:D011758), polystyrene (MESH:D011137), pyrimidines (MESH:D011743), CO2 (MESH:D002245), phospholipids (MESH:D010743), water (MESH:D014867), aldehydes (MESH:D000447), pyrimidine (MESH:C030986), CAs (MESH:D002118), p-CN (MESH:D011285), folic acid (MESH:D005492), glycosides (MESH:D006027), aesculin (MESH:D004929), DMSO (MESH:D004121), cholesterol (MESH:D002784), methicillin (MESH:D008712), hydrogen (MESH:D006859), gentamicin (MESH:D005839), acetic acid (MESH:D019342), PBS (MESH:D007854), alphaMEM (MESH:C420642), benzodioxole (MESH:D052117)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Candida albicans (species) [taxon 5476], Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Pseudomonas aeruginosa (species) [taxon 287], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Staphylococcus aureus (species) [taxon 1280], Ovis aries (domestic sheep, species) [taxon 9940], Enterobacteriaceae (enterobacteria, family) [taxon 543], aureus [taxon 46170]
- **Cell lines:** HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038), ATCC 25923 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), HDF — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_U509), ATCC 27853 — Homo sapiens (Human), Transformed cell line (CVCL_ZH96)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921441/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12921441/full.md

## References

102 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921441/full.md

---
Source: https://tomesphere.com/paper/PMC12921441